Drug intelligence / Profile preview

Qingre Zhike Granule

Development stage: Unknown
Lead developer: Zhangzhou Pien Tze Huang Pharmaceutical
Administration: Oral

Overview

Qingre Zhike Granule is a traditional Chinese medicine (TCM) formulation developed and marketed by Zhangzhou Pientzehuang Pharmaceutical. It is indicated for clearing heat, detoxifying the body, and relieving coughs, particularly those associated with 'lung heat' or common respiratory infections. As a TCM product, its therapeutic effects are attributed to the synergistic action of multiple herbal components that provide anti-inflammatory and antitussive properties. It is typically used to treat symptoms such as cough with yellow phlegm, dry throat, and sore throat. The product is administered orally as a granule that is dissolved in water.

Brand names: Pientzehuang Qingre Zhike Granule
Other names: Qingre Zhike Keli

Beyond the preview

Go deeper on Qingre Zhike Granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingre Zhike Granule.

Explore the full profile